Definitions and classification of malformations of cortical development: practical guidelines
M Severino, AF Geraldo, N Utz, D Tortora, I Pogledic… - Brain, 2020 - academic.oup.com
Malformations of cortical development are a group of rare disorders commonly manifesting
with developmental delay, cerebral palsy or seizures. The neurological outcome is …
with developmental delay, cerebral palsy or seizures. The neurological outcome is …
Phosphatidylinositol 3-kinase, growth disorders, and cancer
MD Goncalves, BD Hopkins… - New England Journal of …, 2018 - Mass Medical Soc
The Central Role of PI3K in Cell Signaling Phosphatidylinositol 3-kinase (PI3K) is involved
in multiple cell processes, including insulin signaling, cell growth, immunity, and brain …
in multiple cell processes, including insulin signaling, cell growth, immunity, and brain …
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
CLOVES syndrome (congenital lipomatous overgrowth, vascular malformations, epidermal
naevi, scoliosis/skeletal and spinal syndrome) is a genetic disorder that results from somatic …
naevi, scoliosis/skeletal and spinal syndrome) is a genetic disorder that results from somatic …
A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
G Canaud, AM Hammill, D Adams, M Vikkula… - Orphanet Journal of …, 2021 - Springer
Background PIK3CA-related disorders include vascular malformations and overgrowth of
various tissues that are caused by postzygotic, somatic variants in the gene encoding …
various tissues that are caused by postzygotic, somatic variants in the gene encoding …
Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical PERFORMUS trial
A Maruani, E Tavernier, O Boccara… - JAMA …, 2021 - jamanetwork.com
Importance Sirolimus is increasingly being used to treat various vascular anomalies,
although evidence of its efficacy is lacking. Objective To assess the efficacy and safety of …
although evidence of its efficacy is lacking. Objective To assess the efficacy and safety of …
A dyadic approach to the delineation of diagnostic entities in clinical genomics
LG Biesecker, MP Adam, FS Alkuraya… - The American Journal of …, 2021 - cell.com
The delineation of disease entities is complex, yet recent advances in the molecular
characterization of diseases provide opportunities to designate diseases in a biologically …
characterization of diseases provide opportunities to designate diseases in a biologically …
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
Glioblastoma is a universally lethal form of brain cancer that exhibits an array of
pathophysiological phenotypes, many of which are mediated by interactions with the …
pathophysiological phenotypes, many of which are mediated by interactions with the …
Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies
KM Keppler‐Noreuil, VER Parker… - American Journal of …, 2016 - Wiley Online Library
The phosphatidylinositol‐3‐kinase (PI3K)/AKT/mTOR signaling pathway plays an essential
role in regulation of normal cell growth, metabolism, and survival. Somatic activating …
role in regulation of normal cell growth, metabolism, and survival. Somatic activating …
[HTML][HTML] Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
VER Parker, KM Keppler-Noreuil, L Faivre, M Luu… - Genetics in …, 2019 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) encompasses a range of debilitating
conditions defined by asymmetric overgrowth caused by mosaic activating PIK3CA variants …
conditions defined by asymmetric overgrowth caused by mosaic activating PIK3CA variants …
The expanding diagnostic toolbox for rare genetic diseases
KD Kernohan, KM Boycott - Nature Reviews Genetics, 2024 - nature.com
Genomic technologies, such as targeted, exome and short-read genome sequencing
approaches, have revolutionized the care of patients with rare genetic diseases. However …
approaches, have revolutionized the care of patients with rare genetic diseases. However …